117 related articles for article (PubMed ID: 3552774)
1. Estimation of B-cell function by the urinary excretion rate of C-peptide in diabetic patients: comparison with C-peptide response to glucagon and to a mixed meal.
Pasquali R; Buratti P; Biso P; Patrono D; Capelli M; Pasqui F; Melchionda N
Diabete Metab; 1987 Feb; 13(1):44-51. PubMed ID: 3552774
[TBL] [Abstract][Full Text] [Related]
2. Residual B-cell function in insulin dependent (Type 1) and non insulin-dependent (Type 2) diabetics (relationship between 24-hour C-peptide excretion and the clinical features of diabetes).
Gerö L; Korányi L; Tamás G
Diabete Metab; 1983 Sep; 9(3):183-7. PubMed ID: 6360742
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of beta cell function in non-insulin-dependent diabetes mellitus (NIDDM) and its correlations with clinico-metabolic parameters].
Santoro E; Gianni R; Maggi L; Tomassini CR; Bisacchi U
G Clin Med; 1989 Feb; 70(2):95-9. PubMed ID: 2666224
[TBL] [Abstract][Full Text] [Related]
4. The role of diminished beta cell reserve and insulin resistance in secondary sulfonylurea failure of type 2 diabetes mellitus.
Rattarasarn C; Thamprasit A; Leelawattana R; Soonthornpun S; Setasuban W
J Med Assoc Thai; 2001 Dec; 84(12):1754-62. PubMed ID: 11999824
[TBL] [Abstract][Full Text] [Related]
5. Twenty-four hour excretion of urinary C-peptide in gestational diabetic women before and after treatment with diet or diet and insulin.
Nordlander E; Hanson U; Stangenberg M; Persson B
Diabetes Res; 1989 Jan; 10(1):25-30. PubMed ID: 2667840
[TBL] [Abstract][Full Text] [Related]
6. [Clinical usefulness of the glucagon test in the study of pancreatic islet cell function].
Llorente I; Goñi MJ; Forga L; Monreal M; Lizcano F; Moncada E
Rev Med Univ Navarra; 1992; 37(1):25-9. PubMed ID: 1626165
[TBL] [Abstract][Full Text] [Related]
7. C-peptide response to glucagon in diabetics with and without complications.
Smith RB; Pyke DA; Watkins PJ; Binder C; Faber OK
N Z Med J; 1979 Apr; 89(634):304-6. PubMed ID: 377156
[TBL] [Abstract][Full Text] [Related]
8. alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients.
Hücking K; Kostic Z; Pox C; Ritzel R; Holst JJ; Schmiegel W; Nauck MA
Diabet Med; 2005 Apr; 22(4):470-6. PubMed ID: 15787675
[TBL] [Abstract][Full Text] [Related]
9. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
Vilsbøll T; Krarup T; Madsbad S; Holst JJ
Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic B-cell function in non-insulin-dependent diabetes mellitus during successive periods of sulfonylurea and insulin treatment: serum C-peptide response to glucagon and urine C-peptide excretion.
Hsieh SD; Iwamoto Y; Matsuda A; Kuzuya T
Endocrinol Jpn; 1987 Aug; 34(4):561-7. PubMed ID: 3315640
[TBL] [Abstract][Full Text] [Related]
11. [Studies on urinary C-peptide excretion in normal children and children with insulin-dependent diabetes mellitus].
Kusayanagi T
Nihon Ika Daigaku Zasshi; 1989 Apr; 56(2):103-22. PubMed ID: 2659621
[TBL] [Abstract][Full Text] [Related]
12. C-peptide response to glucagon in type 2 diabetes mellitus: a comparison with oral glucose tolerance test.
Iwasaki Y; Kondo K; Hasegawa H; Oiso Y
Diabetes Res; 1994; 25(3):129-37. PubMed ID: 7671552
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic beta cell response in insulin treated NIDDM patients limitations of a random C-peptide measurement.
Snehalatha C; Ramachandran A; Mohan V; Viswanathan M
Diabete Metab; 1987 Feb; 13(1):27-30. PubMed ID: 3552773
[TBL] [Abstract][Full Text] [Related]
14. The beta-cell response to glucagon and mixed meal stimulation in non-insulin dependent diabetes.
Gjessing HJ; Damsgaard EM; Matzen LE; Faber OK; Frøland A
Scand J Clin Lab Invest; 1988 Dec; 48(8):771-7. PubMed ID: 3070718
[TBL] [Abstract][Full Text] [Related]
15. C-peptide response to glucagon in young diabetics.
Juang JH; Huang BY; Huang HS; Lin JD; Huang MJ
Taiwan Yi Xue Hui Za Zhi; 1989 Jun; 88(6):579-83. PubMed ID: 2677232
[TBL] [Abstract][Full Text] [Related]
16. Fasting plasma C-peptide, glucagon stimulated plasma C-peptide, and urinary C-peptide in relation to clinical type of diabetes.
Gjessing HJ; Matzen LE; Faber OK; Frøland A
Diabetologia; 1989 May; 32(5):305-11. PubMed ID: 2666217
[TBL] [Abstract][Full Text] [Related]
17. The effect of acute hyperglycemia on the plasma C-peptide response to intravenous glucagon or to a mixed meal in insulin-dependent diabetes mellitus.
Gjessing HJ; Reinholdt B; Faber OK; Pedersen O
Acta Endocrinol (Copenh); 1991 May; 124(5):556-62. PubMed ID: 2028714
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity and reproducibility of urinary C-peptide as estimate of islet B-cell function in insulin-treated diabetes.
Gjessing HJ; Matzen LE; Faber OK; Frøland A
Diabet Med; 1989; 6(4):329-33. PubMed ID: 2524338
[TBL] [Abstract][Full Text] [Related]
19. Lack of influence of residual beta-cell function on the glucagon and pancreatic polypeptide secretion in type I (insulin-dependent) diabetic patients.
Tronier B; Madsbad S; Krarup T; Faber OK
Diabete Metab; 1987 Apr; 13(2):141-3. PubMed ID: 3297833
[No Abstract] [Full Text] [Related]
20. [Secondary failure to oral hypoglycemic drugs: islet cell function determined by urinary C-peptide].
Durruty P; García de los Rios M; López G
Rev Med Chil; 1988 Apr; 116(4):301-7. PubMed ID: 3072638
[No Abstract] [Full Text] [Related]
[Next] [New Search]
